The relationships between the cardiovascular effects, alpha- and beta-adrenoceptor blocking actions and plasma concentration of labetalol in doca hypertensive rats
- PMID: 42517
- DOI: 10.3109/10641967909068627
The relationships between the cardiovascular effects, alpha- and beta-adrenoceptor blocking actions and plasma concentration of labetalol in doca hypertensive rats
Abstract
The relationships between the cardiovascular effects, alpha- and beta-adrenoceptor blocking actions and plasma concentration of labetalol have been examined in conscious DOCA hypertensive rats. Labetalol (10, 30 and 100 mg/kg p.o.) reduced resting heart rate; blood pressure was reduced only by the two higher doses. The effects lasted 5-24 hours. There was a highly significant correlation between the plasma labetalol concentration and its cardiovascular effects. During the labetalol-induced hypotension and bradycardia the vasopressor responses to intra-arterial injections of phenylephrine were reduced; the tachycardia and vasodepressor responses produced by intra-arterial injections of isoprenaline were also reduced. It is concluded that alpha- and beta-adrenoceptor blockade probably account for the labetalol-induced decreases in resting blood pressure and heart rate respectively.
Similar articles
-
Assessment of alpha- and beta-adrenoceptor blocking actions of labetalol.Br J Clin Pharmacol. 1976 Oct;3(5):849-55. doi: 10.1111/j.1365-2125.1976.tb00637.x. Br J Clin Pharmacol. 1976. PMID: 9968 Free PMC article.
-
A review of the animal pharmacology of labetalol, a combined alpha- and beta-adrenoceptor-blocking drug.Br J Clin Pharmacol. 1976 Aug;3(4 Suppl 3):681-4. Br J Clin Pharmacol. 1976. PMID: 10948 Review.
-
Autonomic and antihypertensive activity of oral amosulalol (YM-09538), a combined alpha- and beta-adrenoceptor blocking agent in conscious rats.Jpn J Pharmacol. 1985 May;38(1):31-41. doi: 10.1254/jjp.38.31. Jpn J Pharmacol. 1985. PMID: 2862302
-
Characterization of the adrenoceptor antagonistic and antihypertensive activity of oral amosulalol, a combined alpha- and beta-adrenoceptor antagonist, in hypertensive rats.J Cardiovasc Pharmacol. 1994 Nov;24(5):794-802. doi: 10.1097/00005344-199424050-00015. J Cardiovasc Pharmacol. 1994. PMID: 7532758
-
Pharmacological effects of labetalol in man.Br J Clin Pharmacol. 1976 Aug;3(4 Suppl 3):721-3. Br J Clin Pharmacol. 1976. PMID: 10949 Review.
Cited by
-
Propranolol versus labetalol: interesting differences in efficacy.J Natl Med Assoc. 1985 May;77 Suppl(Suppl):14-23. J Natl Med Assoc. 1985. PMID: 3889356 Free PMC article. Clinical Trial. No abstract available.
-
Properties of labetalol, a combined alpha- and beta-blocking agent, relevant to the treatment of myocardial ischemia.Cardiovasc Drugs Ther. 1988 Sep;2(3):343-53. doi: 10.1007/BF00054642. Cardiovasc Drugs Ther. 1988. PMID: 2908732 Review.
-
Adrenergic receptor effects and antihypertensive actions of beta-adrenoceptor-blocking agents with ancillary properties.Drugs. 1988;36 Suppl 6:10-9. doi: 10.2165/00003495-198800366-00004. Drugs. 1988. PMID: 2908298
Publication types
MeSH terms
Substances
LinkOut - more resources
Other Literature Sources